1. Narciclasine, a novel topoisomerase I inhibitor, exhibited potent anti-cancer activity against cancer cells
   Meichen Wang et al, 2023, Natural Products and Bioprospecting CrossRef
2. Notoginsenoside R1 induces oxidative stress and modulates LPS induced immune microenvironment of nasopharyngeal carcinoma
   Siwei Li et al, 2022, International Immunopharmacology CrossRef
3. Suppression of JAK2/STAT3 Pathway by Notoginsenoside R1 Reduces Epithelial-Mesenchymal Transition in Non-small Cell Lung Cancer
   Min Wan et al, 2024, Molecular Biotechnology CrossRef
4. Downregulation of ATP1A1 Expression by Panax notoginseng (Burk.) F.H. Chen Saponins: A Potential Mechanism of Antitumor Effects in HepG2 Cells and In Vivo
   Xiao-Yi Feng et al, 2021, Frontiers in Pharmacology CrossRef
5. Bioinformatic Analyzes of the Association Between Upregulated Expression of JUN Gene via APOBEC-Induced FLG Gene Mutation and Prognosis of Cervical Cancer
   Huan Chen et al, 2022, Frontiers in Medicine CrossRef